Standout Papers

A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy 2023 2026 202482
  1. A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy (2023)
    Mohit Mathur, Jonathan Barratt et al. New England Journal of Medicine

Immediate Impact

1 from Science/Nature 34 standout
Sub-graph 1 of 13

Citing Papers

Mitochondrial network dynamics in pulmonary disease: Bridging the gap between inflammation, oxidative stress, and bioenergetics
2024 Standout
Linking peripheral atherosclerosis to blood–brain barrier disruption: elucidating its role as a manifestation of cerebral small vessel disease in vascular cognitive impairment
2024 Standout
2 intermediate papers

Works of Jing Xia being referenced

Neuroprotective effect of tanshinone IIA weakens spastic cerebral palsy through inflammation, p38MAPK and VEGF in neonatal rats
2017
A common variant in pre-miR-146 is associated with coronary artery disease risk and its mature miRNA expression
2014

Author Peers

Author Last Decade Papers Cites
Jing Xia 128 75 11 97 19 273
Andrés Carmona 169 128 4 59 18 310
Joe Matsuoka 52 102 9 39 17 304
Linshuai Xu 144 55 17 53 16 285
Kana Ide 152 71 4 56 14 290
Shoko Ohno 151 109 17 51 14 319
Cathy Gomila 124 31 20 29 22 303
Yiming Shi 152 53 17 43 23 324
Haruhiko Hirai 151 76 5 51 16 330
Xiujie Liang 138 84 10 83 18 333
Ruimin Hu 123 164 9 29 21 289

All Works

Loading papers...

Rankless by CCL
2026